Brokers Issue Forecasts for RCKT FY2029 Earnings
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) – Equities researchers at Wedbush issued their FY2029 earnings per share estimates for Rocket Pharmaceuticals in a report released on Friday, February 28th. Wedbush analyst Y. Zhong forecasts that the biotechnology company will post earnings of $0.01 per share for the year. Wedbush currently has a “Outperform” rating […]
